Ocular Therapeutix (OCUL) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts OCUL Hot Sheet
Join SI Premium – FREE
Ocular Therapeutix (NASDAQ: OCUL) reported Q3 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $15.42 million versus the consensus estimate of $17.13 million.
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
- Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
- Accuray (ARAY) Tops Q4 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
